Intramedullary Nail Versus Sliding Hip Screw Inter-Trochanteric Evaluation
INSITE
A Multi-Center Randomized Controlled Trial of Intramedullary Nails Versus Sliding Hip Screws in the Management of Intertrochanteric Fractures of the Hip
2 other identifiers
interventional
880
12 countries
26
Brief Summary
The purpose of this study is to assess the impact of Gamma3 intramedullary nails versus sliding hip screws on health-related quality of life as measured by the EuroQuol-5D at 52 weeks in individuals with trochanteric fractures. Secondary outcomes include revision surgery rates, fracture healing rates, fracture related adverse events, and health-related quality of life, including the Parker mobility score and Harris Hip Score.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Dec 2011
Longer than P75 for not_applicable
26 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 20, 2011
CompletedFirst Posted
Study publicly available on registry
June 27, 2011
CompletedStudy Start
First participant enrolled
December 1, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2017
CompletedMarch 7, 2019
March 1, 2019
5.3 years
June 20, 2011
March 5, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Health Related Quality of Life
To assess the impact of Gamma3 intramedullary nails versus sliding hip screws on health-related quality of life as measured by the EuroQol-5D at 52 weeks in individuals with trochanteric fractures.
Up to 104 weeks
Secondary Outcomes (4)
Health Related Quality of Life
Up to 104 weeks
Fracture healing rates
Up to 104 weeks
Fracture-related adverse events
Up to 104 weeks
Revision surgery rates
Up to 104 weeks
Study Arms (2)
1
ACTIVE COMPARATORGamma3 Intramedullary Nails
2
ACTIVE COMPARATORSliding Hip Screws
Interventions
The Gamma3 nail is cannulated for Guide-Wire-controlled insertion, and features a conical tip for optimal alignment with the inner part of the cortical bone. A single distal Locking Screw is provided to stabilize the nail in the medullary canal and to help to prevent rotation in complex fractures.
The sliding hip screw is a single larger diameter partially threaded screw, which is affixed to the proximal femur with a side plate (with a minimum of two holes and a maximum of four holes) and no supplemental fixation.
Eligibility Criteria
You may qualify if:
- Adult men or women aged 18 years and older (with no upper age limit).
- An intertrochanteric fracture (stable or unstable), AO Type 31-A1 or 31-A2, confirmed with anteroposterior and lateral hip radiographs, computed tomography, or magnetic resonance imaging (MRI).
- Low energy fracture (defined as a fall from standing height).
- No other major trauma.
- Patient was ambulatory prior to fracture, though they may have used an aid such as a cane or a walker.
- Anticipated medical optimization of the patient for operative fixation of the proximal femur.
- Operative treatment within 7 days after the trauma.(Operative treatment should take place as soon as possible as permitted by each institution's standard of care.)
- Provision of informed consent by patient or proxy.
You may not qualify if:
- Associated major injuries of the lower extremity (i.e., ipsilateral and/or contralateral fractures of the foot, ankle, tibia, fibula, or knee; dislocations of the ankle, knee, or hip).
- Retained hardware around the affected proximal femur.
- Infection around the proximal femur (i.e., soft tissue or bone).
- Patients with disorders of bone metabolism other than osteoporosis (i.e., Paget's disease, renal osteodystrophy, or osteomalacia).
- Patients with Parkinson's disease severe enough to increase the likelihood of falling or severe enough to compromise rehabilitation.
- Patients with a subtrochanteric fracture.
- Patients with a pathologic fracture.
- Patients with a reverse oblique fracture pattern, fracture AO Type 31-A3.
- Obesity in the judgment of the attending surgeon.
- Off-label use of the implant.
- Patients with a previous history of frank dementia that would interfere with assessment of the primary outcome (i.e., EQ-5D at 1 year).
- Likely problems, in the judgment of the Site Investigators, with maintaining follow-up. We will, for example, exclude patients with no fixed address, those who report a plan to move out of town in the next year, or intellectually challenged patients without adequate family support.
- Patient is enrolled in another ongoing drug or surgical intervention trial.
- If the attending surgeon believes that there is another reason to exclude this patient from INSITE. This reason will be documented on the case report forms (CRFs).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Stryker Trauma and Extremitieslead
- Global Research Solutionscollaborator
Study Sites (26)
Community Regional Medical Center
Fresno, California, 93721, United States
San Francisco General Hospital
San Francisco, California, 94110, United States
Beth Israel Deaconess Medical Center
Boston, Massachusetts, 02215, United States
Lahey Clinic
Burlington, Massachusetts, 01805, United States
Temple University Hospital
Philadelphia, Pennsylvania, 19140, United States
Scott&White Memorial Hospital
Temple, Texas, 76508, United States
Inova Fairfax Hospital
Falls Church, Virginia, 22042, United States
The Royal Melbourne Hospital
Parkville, Victoria, 3039, Australia
Health Sciences Centre Winnipeg
Winnipeg, Manitoba, R3A 1R9, Canada
St. Michael's Hospital
Toronto, Ontario, M5C 1R6, Canada
Chaoyang Hospital
Beijing, Beijing Municipality, 100020, China
Sixth People's Hospital
Shanghai, Shanghai Municipality, 200233, China
2nd Affiliated Hospital of Zhejiang University
Hangzhou, Zhejiang, 310009, China
Clinica El Rosario Sede El Tesoro
Medellín, Antioquia, Colombia
Hospital Universitario Santa Clara
Bogotá, Cundinamarca, Colombia
Aarhus University Hospital
Aarhus, 8000, Denmark
Universitätsklinikum Schleswig-Holstein, Campus Lübeck
Lübeck, 23538, Germany
Robert-Bosch-Krankenhaus
Stuttgart, 70376, Germany
Tsukuba Medical Center
Tsukuba, Ibaraki, 305-8558, Japan
Onze Lieve Vrouwe Gasthuis
Amsterdam, 1091, Netherlands
Helse Sunnmore Alesund Sjukehus
Ålesund, 6026, Norway
Charlotte Maxeke Johannesburg Academic Hospital
Parktown, 2193, South Africa
Frenchay Hospital
Bristol, BS16 1LE, United Kingdom
The Royal Liverpool University Hospital
Liverpool, L7 8XP, United Kingdom
The Royal Berkshire Hospital
Reading, RG1 5AN, United Kingdom
Southampton General Hospital
Southampton, SO16 6YD, United Kingdom
Related Publications (4)
Ahrengart L, Tornkvist H, Fornander P, Thorngren KG, Pasanen L, Wahlstrom P, Honkonen S, Lindgren U. A randomized study of the compression hip screw and Gamma nail in 426 fractures. Clin Orthop Relat Res. 2002 Aug;(401):209-22. doi: 10.1097/00003086-200208000-00024.
PMID: 12151898BACKGROUNDBhandari M, Schemitsch E, Jonsson A, Zlowodzki M, Haidukewych GJ. Gamma nails revisited: gamma nails versus compression hip screws in the management of intertrochanteric fractures of the hip: a meta-analysis. J Orthop Trauma. 2009 Jul;23(6):460-4. doi: 10.1097/BOT.0b013e318162f67f.
PMID: 19550235BACKGROUNDParker MJ, Handoll HH. Gamma and other cephalocondylic intramedullary nails versus extramedullary implants for extracapsular hip fractures in adults. Cochrane Database Syst Rev. 2008 Jul 16;(3):CD000093. doi: 10.1002/14651858.CD000093.pub4.
PMID: 18646058BACKGROUNDSchemitsch EH, Nowak LL, Schulz AP, Brink O, Poolman RW, Mehta S, Stengel D, Zhang CQ, Martinez S, Kinner B, Chesser TJS, Bhandari M; INSITE Investigators. Intramedullary Nailing vs Sliding Hip Screw in Trochanteric Fracture Management: The INSITE Randomized Clinical Trial. JAMA Netw Open. 2023 Jun 1;6(6):e2317164. doi: 10.1001/jamanetworkopen.2023.17164.
PMID: 37278998DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Mohit Bhandari, MD, PhD, FRCSC
Global Research Solutions
- STUDY DIRECTOR
Georgia Mitchell
Stryker Trauma and Extremities
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 20, 2011
First Posted
June 27, 2011
Study Start
December 1, 2011
Primary Completion
March 1, 2017
Study Completion
March 1, 2017
Last Updated
March 7, 2019
Record last verified: 2019-03
Data Sharing
- IPD Sharing
- Will not share